Equal access to care and nurse navigation leads to equitable outcomes for minorities with aggressive large B‐cell lymphoma-Reference-Cited by-同舟云学术

Equal access to care and nurse navigation leads to equitable outcomes for minorities with aggressive large B‐cell lymphoma

Published:2021-07-21 Issue:21 Volume:127 Page:3991-3997
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Hu Bei¹,Boselli Danielle²,Pye Lisa M.³,Chen Tommy²,Bose Rupali²,Symanowski James T.²,Blackley Kris³,Moyo Tamara K.¹,Jacobs Ryan¹,Park Steven I.¹,Soni Amy¹,Avalos Belinda R.¹,Copelan Edward A.¹,Raghavan Derek⁴,Ghosh Nilanjan¹^ORCID

Affiliation:

1. Department of Hematologic Oncology and Blood Disorders Levine Cancer Institute/Atrium Health Charlotte North Carolina

2. Department of Biostatistics Levine Cancer Institute/Atrium Health Charlotte North Carolina

3. Department of Patient Navigation Levine Cancer Institute/Atrium Health Charlotte North Carolina

4. Levine Cancer Institute/Atrium Health Charlotte North Carolina

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33779

Reference33 articles.

1. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

2. Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma

3. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

4. Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma

5. Phase II Study of Dose-Adjusted EPOCH and Rituximab in Untreated Diffuse Large B-Cell Lymphoma With Analysis of Germinal Center and Post-Germinal Center Biomarkers

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes of patients with newly diagnosed large B-cell lymphoma in a safety-net hospital system;Blood Neoplasia;2024-09

2. Disparities in relapsed or refractory multiple myeloma: recommendations from an interprofessional consensus panel;Blood Cancer Journal;2024-08-27

3. Impact of Socioeconomic Status on Patient Adherence in Managing Renal Masses;Urology Practice;2024-07

4. Chimeric Antigen Receptor T-Cell Access in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Association of Access with Social Determinants of Health and Travel Time to Treatment Centers;Transplantation and Cellular Therapy;2024-07

5. Patient Navigation in Cancer Treatment: A Systematic Review;Current Oncology Reports;2024-04-06